Feedback / Questions
entinostat (SNDX-275) - Kyowa Hakko Kirin, Syndax
KHK2375: Completion of P2 trial (NCT03291886) for advanced or recurrent hormone receptor-positive breast cancer in November 2021
(Kyowa Hakko Kirin Pharma)
-
Aug 2, 2019 -
Q2 2019 Results
Trial completion date
https://ir.kyowakirin.com/en/library/earnings.html
Aug 2, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious